# OnCo record paper-trastuzumab-deruxtecan-tnbc-expert-opin-biol-ther-2021 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-trastuzumab-deruxtecan-tnbc-expert-opin-biol-ther-2021/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-trastuzumab-deruxtecan-tnbc-expert-opin-biol-ther-2021" ;
  schema:name "Antibody-drug conjugates in metastatic triple negative breast cancer: a spotlight on sacituzumab govitecan, ladiratuzumab vedotin, and trastuzumab deruxtecan"@en ;
  schema:description "Review on Trastuzumab deruxtecan in Triple-negative breast cancer, in Expert opinion on biological therapy (2021), one of the most cited Europe PMC records with Trastuzumab deruxtecan in its title."@en ;
  schema:url <https://onco.cc/key-papers/paper-trastuzumab-deruxtecan-tnbc-expert-opin-biol-ther-2021/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1080/14712598.2021.1840547>, <https://pubmed.ncbi.nlm.nih.gov/33089726/>, <https://europepmc.org/article/MED/33089726> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1080/14712598.2021.1840547> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "McGuinness JE, Kalinsky K" .